Menu
Home
Forums
Forums
Quick Links
Search Forums
Recent Posts
job listings
catering
whistleblower info
legal help
advertise on CP
submit press release
Menu
Log in
Sign up
Search titles only
Posted by Member:
Separate names with a comma.
Newer Than:
Search this thread only
Search this forum only
Display results as threads
More...
Useful Searches
Recent Posts
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Pharma/Biotech Companies - In the News
>
Convalescent plasma fails phase 2 in moderate COVID-19 patients
>
Reply to Thread
Name:
Verification:
Answer the above question:
(
CustomImgCaptcha
By
Surrey Forum
)
Message:
<p>[QUOTE="cafead, post: 6469140, member: 1"]via A randomized phase 2 clinical trial has found convalescent plasma has no effect on progression to severe disease or all-cause mortality in COVID-19 patients. The data raise significant doubts about the efficacy of an intervention that has been given to more than 100,000 people in the U.S.</p><p><br /></p><p><a href="https://bit.ly/3miRbzI" target="_blank" class="externalLink ProxyLink" data-proxy-href="https://bit.ly/3miRbzI" rel="nofollow">article source</a>[/QUOTE]</p><p><br /></p>
[QUOTE="cafead, post: 6469140, member: 1"]via A randomized phase 2 clinical trial has found convalescent plasma has no effect on progression to severe disease or all-cause mortality in COVID-19 patients. The data raise significant doubts about the efficacy of an intervention that has been given to more than 100,000 people in the U.S. [url="https://bit.ly/3miRbzI"]article source[/url][/QUOTE]
Your name or email address:
Do you already have an account?
No, create an account now.
Yes, my password is:
Forgot your password?
Stay logged in
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Pharma/Biotech Companies - In the News
>
Convalescent plasma fails phase 2 in moderate COVID-19 patients
>
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Pharma/Biotech Companies - In the News
>
Convalescent plasma fails phase 2 in moderate COVID-19 patients
>